Annual EBIT
-$195.69 M
+$28.22 M+12.60%
December 31, 2023
Summary
- As of February 12, 2025, BLUE annual earnings before interest & taxes is -$195.69 million, with the most recent change of +$28.22 million (+12.60%) on December 31, 2023.
- During the last 3 years, BLUE annual EBIT has risen by +$363.57 million (+65.01%).
- BLUE annual EBIT is now -1192.34% below its all-time high of -$15.14 million, reached on December 31, 2011.
Performance
BLUE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$55.09 M
+$20.83 M+27.44%
September 30, 2024
Summary
- As of February 12, 2025, BLUE quarterly earnings before interest & taxes is -$55.09 million, with the most recent change of +$20.83 million (+27.44%) on September 30, 2024.
- Over the past year, BLUE quarterly EBIT has increased by +$9.86 million (+15.18%).
- BLUE quarterly EBIT is now -165.83% below its all-time high of $83.68 million, reached on December 31, 2022.
Performance
BLUE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$272.80 M
+$27.83 M+9.26%
September 30, 2024
Summary
- As of February 12, 2025, BLUE TTM earnings before interest & taxes is -$272.80 million, with the most recent change of +$27.83 million (+9.26%) on September 30, 2024.
- Over the past year, BLUE TTM EBIT has increased by +$11.03 million (+3.89%).
- BLUE TTM EBIT is now -5211.55% below its all-time high of -$5.14 million, reached on March 31, 2012.
Performance
BLUE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BLUE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | +15.2% | +3.9% |
| 3 y3 years | +65.0% | -165.8% | -21.8% |
| 5 y5 years | +65.6% | +73.7% | +56.4% |
BLUE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.4% | -165.8% | +59.1% | -676.0% | +52.1% |
| 5 y | 5-year | at high | +65.4% | -165.8% | +73.3% | -676.0% | +56.4% |
| alltime | all time | -1192.3% | +65.6% | -165.8% | +73.7% | -5211.6% | +63.0% |
Bluebird Bio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$55.09 M(-27.4%) | -$272.80 M(-9.3%) |
| Jun 2024 | - | -$75.92 M(+16.9%) | -$300.63 M(+5.9%) |
| Mar 2024 | - | -$64.95 M(-15.5%) | -$283.83 M(+45.0%) |
| Dec 2023 | -$195.69 M(-12.6%) | -$76.85 M(-7.3%) | -$195.69 M(+456.6%) |
| Sep 2023 | - | -$82.92 M(+40.3%) | -$35.16 M(-9.2%) |
| Jun 2023 | - | -$59.12 M(-354.8%) | -$38.72 M(-51.8%) |
| Mar 2023 | - | $23.20 M(-72.3%) | -$80.36 M(-64.1%) |
| Dec 2022 | -$223.90 M(-60.4%) | $83.68 M(-196.8%) | -$223.90 M(-49.4%) |
| Sep 2022 | - | -$86.48 M(-14.2%) | -$442.25 M(-9.8%) |
| Jun 2022 | - | -$100.76 M(-16.3%) | -$490.05 M(-9.9%) |
| Mar 2022 | - | -$120.35 M(-10.6%) | -$543.99 M(-4.5%) |
| Dec 2021 | -$565.11 M(+1.0%) | -$134.67 M(+0.3%) | -$569.74 M(+0.0%) |
| Sep 2021 | - | -$134.27 M(-13.2%) | -$569.67 M(-9.0%) |
| Jun 2021 | - | -$154.70 M(+5.9%) | -$625.92 M(+25.5%) |
| Mar 2021 | - | -$146.09 M(+8.5%) | -$498.82 M(-10.8%) |
| Dec 2020 | -$559.26 M(-0.7%) | -$134.60 M(-29.3%) | -$559.26 M(+38.2%) |
| Sep 2020 | - | -$190.52 M(+590.3%) | -$404.64 M(-4.5%) |
| Jun 2020 | - | -$27.60 M(-86.6%) | -$423.73 M(-29.2%) |
| Mar 2020 | - | -$206.53 M(-1131.8%) | -$598.62 M(+6.3%) |
| Dec 2019 | -$562.96 M(-1.1%) | $20.02 M(-109.5%) | -$562.96 M(-23.7%) |
| Sep 2019 | - | -$209.61 M(+3.5%) | -$737.78 M(+8.8%) |
| Jun 2019 | - | -$202.49 M(+18.5%) | -$677.94 M(+8.7%) |
| Mar 2019 | - | -$170.88 M(+10.4%) | -$623.81 M(+9.6%) |
| Dec 2018 | -$569.02 M | -$154.81 M(+3.4%) | -$569.02 M(+7.0%) |
| Sep 2018 | - | -$149.77 M(+1.0%) | -$531.72 M(+15.6%) |
| Jun 2018 | - | -$148.35 M(+27.8%) | -$459.87 M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$116.09 M(-1.2%) | -$380.31 M(+14.3%) |
| Dec 2017 | -$332.69 M(+26.1%) | -$117.50 M(+50.8%) | -$332.69 M(+15.9%) |
| Sep 2017 | - | -$77.92 M(+13.3%) | -$286.95 M(+0.3%) |
| Jun 2017 | - | -$68.79 M(+0.5%) | -$286.07 M(+3.7%) |
| Mar 2017 | - | -$68.48 M(-4.6%) | -$275.85 M(+4.6%) |
| Dec 2016 | -$263.74 M(+58.7%) | -$71.76 M(-6.9%) | -$263.74 M(+9.6%) |
| Sep 2016 | - | -$77.04 M(+31.5%) | -$240.61 M(+16.6%) |
| Jun 2016 | - | -$58.57 M(+3.9%) | -$206.34 M(+4.3%) |
| Mar 2016 | - | -$56.37 M(+15.9%) | -$197.82 M(+19.1%) |
| Dec 2015 | -$166.17 M(+175.2%) | -$48.63 M(+13.7%) | -$166.17 M(+21.3%) |
| Sep 2015 | - | -$42.77 M(-14.5%) | -$136.98 M(+23.3%) |
| Jun 2015 | - | -$50.05 M(+102.5%) | -$111.14 M(+49.3%) |
| Mar 2015 | - | -$24.71 M(+27.1%) | -$74.42 M(+23.3%) |
| Dec 2014 | -$60.38 M(+142.0%) | -$19.45 M(+14.9%) | -$60.38 M(+23.1%) |
| Sep 2014 | - | -$16.93 M(+27.0%) | -$49.05 M(+28.2%) |
| Jun 2014 | - | -$13.33 M(+25.0%) | -$38.27 M(+31.4%) |
| Mar 2014 | - | -$10.67 M(+31.5%) | -$29.13 M(+16.8%) |
| Dec 2013 | -$24.95 M(+5.2%) | -$8.12 M(+31.8%) | -$24.95 M(-3.3%) |
| Sep 2013 | - | -$6.16 M(+46.8%) | -$25.79 M(+4.6%) |
| Jun 2013 | - | -$4.19 M(-35.3%) | -$24.66 M(-1.6%) |
| Mar 2013 | - | -$6.48 M(-27.6%) | -$25.06 M(+5.7%) |
| Dec 2012 | -$23.72 M(+56.6%) | -$8.96 M(+78.3%) | -$23.72 M(+60.7%) |
| Sep 2012 | - | -$5.02 M(+9.2%) | -$14.76 M(+51.6%) |
| Jun 2012 | - | -$4.60 M(-10.4%) | -$9.74 M(+89.6%) |
| Mar 2012 | - | -$5.14 M | -$5.14 M |
| Dec 2011 | -$15.14 M | - | - |
FAQ
- What is bluebird bio annual earnings before interest & taxes?
- What is the all time high annual EBIT for bluebird bio?
- What is bluebird bio annual EBIT year-on-year change?
- What is bluebird bio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for bluebird bio?
- What is bluebird bio quarterly EBIT year-on-year change?
- What is bluebird bio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for bluebird bio?
- What is bluebird bio TTM EBIT year-on-year change?
What is bluebird bio annual earnings before interest & taxes?
The current annual EBIT of BLUE is -$195.69 M
What is the all time high annual EBIT for bluebird bio?
bluebird bio all-time high annual earnings before interest & taxes is -$15.14 M
What is bluebird bio annual EBIT year-on-year change?
Over the past year, BLUE annual earnings before interest & taxes has changed by +$28.22 M (+12.60%)
What is bluebird bio quarterly earnings before interest & taxes?
The current quarterly EBIT of BLUE is -$55.09 M
What is the all time high quarterly EBIT for bluebird bio?
bluebird bio all-time high quarterly earnings before interest & taxes is $83.68 M
What is bluebird bio quarterly EBIT year-on-year change?
Over the past year, BLUE quarterly earnings before interest & taxes has changed by +$9.86 M (+15.18%)
What is bluebird bio TTM earnings before interest & taxes?
The current TTM EBIT of BLUE is -$272.80 M
What is the all time high TTM EBIT for bluebird bio?
bluebird bio all-time high TTM earnings before interest & taxes is -$5.14 M
What is bluebird bio TTM EBIT year-on-year change?
Over the past year, BLUE TTM earnings before interest & taxes has changed by +$11.03 M (+3.89%)